bile duct cancer
Showing 1 - 25 of >10,000
Bile Duct Cancer Trial (envolizumab , sovalteinib)
Not yet recruiting
- Bile Duct Cancer
- envolizumab , sovalteinib
- (no location specified)
Jun 20, 2023
Looking At Bile Duct Cancer Patient Experience Patterns in
Not yet recruiting
- Bile Duct Cancer
- (no location specified)
Jan 20, 2023
Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,
Active, not recruiting
- Advanced Bile Duct Carcinoma
- +17 more
- Irinotecan
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer
Recruiting
- Metastatic Colorectal Cancer (Mcrc)
- +7 more
- Floxuridine
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Inoperable Disease, Bile Duct Cancer Trial in Cluj-Napoca (Endoscopic ultrasound with fine needle biopsy)
Recruiting
- Inoperable Disease
- Bile Duct Cancer
- Endoscopic ultrasound with fine needle biopsy
-
Cluj-Napoca, Cluj, RomaniaIRGH "O. Fodor"
Jun 14, 2022
Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,
Not yet recruiting
- Biliary Cancer
- +2 more
- oxaliplatin
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Ampullary Cancer, Bile Duct Cancer, Pancreas Cancer Trial in Zhanjiang (Modified Blumgart Anastomosis in LPD, conventional
Enrolling by invitation
- Ampullary Cancer
- +3 more
- Modified Blumgart Anastomosis in LPD
- conventional Blumgart anastomosis in LPD
-
Zhanjiang, Guangdong, ChinaThe Affiliated Hospital of Guangdong Medical University
Oct 7, 2023
Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)
Not yet recruiting
- Bile Duct Cancer
- +4 more
- Gemcitabine
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 23, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)
Recruiting
- Pancreatic Cancer
- Cholangiocarcinoma
- [68Ga]Ga-FAPI-46 PET/CT
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location VUmc
Jul 13, 2023
ful Mutations in Solid Tumor Characterized by Next Generation
Recruiting
- Solid Tumor
- +13 more
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Sep 8, 2023
Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)
Recruiting
- Colorectal Cancer
- +6 more
- CEA-targeted CAR-T cells
-
Hangzhou, Zhejiang, China
- +1 more
Sep 18, 2023
Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)
Not yet recruiting
- Biliary Tract Carcinoma
- +2 more
- Gemcitabine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin
Sep 15, 2023
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)
Terminated
- Cholangiocarcinoma
- Bile Duct Cancer
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Nov 28, 2022
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)
Recruiting
- Bile Duct Adenocarcinoma
- surufatinib plus cadonilimab
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Oct 15, 2023
Hilar Cholangiocarcinoma Trial in Leipzig (Photosensitizer, Radiofrequency ablation (RFA))
Recruiting
- Hilar Cholangiocarcinoma
- Photosensitizer
- Radiofrequency ablation (RFA)
-
Leipzig, GermanyUniversity Hospital of Leipzig, Department of Gastroenterology
Oct 14, 2022
Liver and Biliary Cancer Patients Treated With PD-1 Combination
Active, not recruiting
- Hepatocellular Carcinoma
- Bile Duct Cancer
- [68Ga]FAPI PET/CT and [18F]FDG PET/CT
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Dec 14, 2022
Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)
Recruiting
- Peritoneal Carcinomatosis
- +7 more
- PIPAC with Nal-IRI
-
Ghent, East-Flanders, BelgiumUZ Ghent
Dec 28, 2022
Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,
Suspended
- Distal Bile Duct Adenocarcinoma
- +7 more
- Cisplatin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Bile Duct Obstruction, Extrahepatic Trial in Korea, Republic of (Cytology staining)
Recruiting
- Bile Duct Obstruction, Extrahepatic
- Cytology staining
-
Seongnam, Bundang-gu, Korea, Republic of
- +4 more
Aug 2, 2022
Intrahepatic Cholangiocarcinoma Trial in Philadelphia (Perflutren Protein-Type A Microspheres, Contrast-Enhanced Ultrasound)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Perflutren Protein-Type A Microspheres
- Contrast-Enhanced Ultrasound
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Apr 7, 2022
Bile Duct Cancer, Pancreas Cancer Trial in Dallas (Interventional Endoscopy procedures)
Completed
- Bile Duct Cancer
- Pancreas Cancer
- Interventional Endoscopy procedures
-
Dallas, TexasMethodist Dallas Medical Center
Nov 9, 2021
Cholangio Carcinoma Trial in Hong Kong (SIRT Yttrium-90)
Active, not recruiting
- Cholangio Carcinoma
- SIRT Yttrium-90
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
May 3, 2022